Inter-society standards for the performance of brachytherapy: a joint report from ABS, ACMP and ACRO

Pilomatrix Carcinoma with Lymph Node and Pulmonary Metastases

“…192 Ir dwell positions and times are adjusted to minimize the dose to organs at risk. In accordance with the American Brachytherapy Society (ABS), American College of Medical Physics (ACMP) and American College of Radiation Oncology (ACRO) intersociety standards for the performance of BRT [26], prescribed and reported doses are specified by D 90 , as determined by dose-volume histograms (Figure 4b). Similarly, dose heterogeneity is specified volumetrically by V 100 , V 150 , and V 200 .…”

Recommendations of the American Association of Physicists in Medicine on dosimetry, imaging, and quality assurance procedures for 90Y microsphere brachytherapy in the treatment of hepatic malignancies

“…Nag et al 59 recommended a 20% overall deviation from the prescribed dose as a tolerance criterion for most goodquality brachytherapy implants. Brachytherapy implants that could not achieve this tolerance were suggested to consider the following before initiating the therapy: to reposition applicators or sources, adjust the written directive, or abort the procedure.…”

Brachytherapy for cervical cancer: guidelines to facilitate patient-centred care in a multidisciplinary environment

“…5,6 Currently, there are various sets of brachytherapy-related guidelines to assist institutions in developing or optimising brachytherapy facilities regarding treatment regimes, techniques, dose specification and treatment planning methods. 7 Viswanathan and Thomadsen reported that the updated 2012 recommendations of the American Brachytherapy Society also address image-guided treatment planning and delivery and recommended reporting parameters for quality assurance. 8 However, these guidelines for service providers and members of multidisciplinary teams (radiation oncologists, medical physicists, radiation therapists and oncology nurses) are limited to the organisational and technical aspects of high dose rate (HDR)-intracavitary brachytherapy (ICBT) treatment delivery.…”